~~<i id='D3409B9AB5'><strike id='D3409B9AB5'><tt id='D3409B9AB5'><pre id='D3409B9AB5'></pre></tt></strike></i>~~

Home» explore» explore

explore

author：leisure time 2025-10-01 03:45:22 Page View：272

HHS 2020 — PhRMA is suing the Biden administration over its new Medicare drug price negotiation program. Graeme Sloan/Sipa USA

WASHINGTON — After losing the drug pricing fight on Capitol Hill, PhRMA is taking its battle to the courts.

The pharmaceutical industry’s biggest lobbying group on Wednesday filed a long-expected lawsuit challenging Democrats’ drug pricing law that allowed Medicare to start negotiating prices for certain medicines.

PhRMA joins a growing club of companies and trades challenging the law. Merck, Bristol Myers Squibb, and the Chamber of Commerce have already filed similar suits in different courts.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Senator probes 340B programs at Cleveland Clinic, Bon Secours
Next article： How to save PrEP access — and even expand it

knowledge

Moonlake's readout produced a cash windfall. Risks remain

MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

Most antidepressants don't work on kids, teens, study finds

MattDtrich/TheIndianapolisStar/APThevastmajorityofantidepressantsgiventokidsandteensareineffectivean

Drug repurposing or repositioning? The language matters

AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

The effects of a landmark ruling on DNA ownership are becoming clearer

AdobeToday,ifyouwanttoknowwhatscaryfamilyhealthsecretslayburiedinyourDNAorgetscreenedforalurkingcanc